4 terminated. 4 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 1 | 3 | Terminated 3 |
Follow bemcentinib: new trials by email Literature Review of bemcentinib trials Research Report on bemcentinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma bemcentinib, pacritinib - Advanced Lung Adenocarcinoma | Phase 1 / Phase 2 | Terminated | The University of Texas Health Science Center at San Antonio | 4 | 2024-12-27 | 2026-05-26 |
| A Clinical Study of Bemcentinib With Standard of Care Chemoimmunotherapy in Untreated Advanced/Metastatic Non-small Cell Lung Cancer Patients With a Mutation in the STK11 Gene Bemcentinib, Pembrolizumab, Pemetrexed - Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Terminated | BerGenBio ASA | 26 | 2023-03-03 | 2025-10-29 |
| Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer Bemcentinib, Nab-paclitaxel, Gemcitabine - Cancer of Pancreas | Phase 1 / Phase 2 | Terminated | University of Texas Southwestern Medical Center | 9 | 2019-01-03 | 2023-11-09 |
| Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC Bemcentinib; pembrolizumab - Triple Negative Breast Cancer, Inflammatory Breast Cancer Stage IV | Phase 2 | Terminated | BerGenBio ASA | 29 | 2017-07-26 | 2021-11-09 |
Carcinoma, Non-Small-Cell Lung (1) · Inflammatory Breast Neoplasms (1) · Pancreatic Neoplasms (1) · Triple Negative Breast Neoplasms (1)
BerGenBio ASA (2) · The University of Texas Health Science Center at San Antonio (1) · University of Texas Southwestern Medical Center (1)
United States (4) · Spain (2) · France (1) · Greece (1) · Hungary (1) · Italy (1) · Norway (1) · Poland (1) · United Kingdom (1)
Syed Kazmi, MD (1)
2016 (1), R01CA269766 (1)